Lv6
2890 积分 2023-10-23 加入
Targeting PDGFR, EGFR, FGFR, and VEGFR: Key Receptor Tyrosine Kinases‐Driven Metabolic Reprogramming in Pulmonary Arterial Hypertension
2天前
已完结
Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease
10天前
已关闭
Cannabis-Based Products for Chronic Pain
29天前
已完结
Advances in the Quest for Safe and Effective Drugs That Target the Cannabinoid Receptor Type 1 (CB1)
29天前
已完结
Rational design of Gi-biased CB1 agonist with reduced side effects
30天前
已完结
The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson’s disease
3个月前
已完结
The endometrial carcinoma market
3个月前
已完结
Atopic dermatitis
4个月前
已完结
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
4个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
4个月前
已完结
皖公网安备34019202002308
